Economic Evaluation of Canagliflozin versus Glimepiride and Sitagliptin in Dual Therapy with Metformin for the Treatment of Type 2 Diabetes in Italy | Zendy

AI Assistant Blog Pricing

Open Access

Economic Evaluation of Canagliflozin versus Glimepiride and Sitagliptin in Dual Therapy with Metformin for the Treatment of Type 2 Diabetes in Italy

Author(s) -

Roberto Ravasio,

Patrizia Pisarra,

Roberto Porzio,

Marco Comaschi

Publication year - 2016

Publication title -

global and regional health technology assessment

Language(s) - English

Resource type - Journals

eISSN - 2283-5733

pISSN - 2284-2403

DOI - 10.5301/grhta.5000229

Subject(s) - canagliflozin , sitagliptin , glimepiride , medicine , metformin , type 2 diabetes mellitus , type 2 diabetes , glycemic , diabetes mellitus , urology , pharmacology , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.